Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle
Yvan Torrente, … , Giulio Cossu, Nereo Bresolin
Yvan Torrente, … , Giulio Cossu, Nereo Bresolin
Published July 15, 2004
Citation Information: J Clin Invest. 2004;114(2):182-195. https://doi.org/10.1172/JCI20325.
View: Text | PDF
Article

Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

  • Text
  • PDF
Abstract

Duchenne muscular dystrophy (DMD) is a common X-linked disease characterized by widespread muscle damage that invariably leads to paralysis and death. There is currently no therapy for this disease. Here we report that a subpopulation of circulating cells expressing AC133, a well-characterized marker of hematopoietic stem cells, also expresses early myogenic markers. Freshly isolated, circulating AC133+ cells were induced to undergo myogenesis when cocultured with myogenic cells or exposed to Wnt-producing cells in vitro and when delivered in vivo through the arterial circulation or directly into the muscles of transgenic scid/mdx mice (which allow survival of human cells). Injected cells also localized under the basal lamina of host muscle fibers and expressed satellite cell markers such as M-cadherin and MYF5. Furthermore, functional tests of injected muscles revealed a substantial recovery of force after treatment. As these cells can be isolated from the blood, manipulated in vitro, and delivered through the circulation, they represent a possible tool for future cell therapy applications in DMD disease or other muscular dystrophies.

Authors

Yvan Torrente, Marzia Belicchi, Maurilio Sampaolesi, Federica Pisati, Mirella Meregalli, Giuseppe D’Antona, Rossana Tonlorenzi, Laura Porretti, Manuela Gavina, Kamel Mamchaoui, Maria Antonietta Pellegrino, Denis Furling, Vincent Mouly, Gillian S. Butler-Browne, Roberto Bottinelli, Giulio Cossu, Nereo Bresolin

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
Contribution of circulating AC133+ stem cells to the replenishment of th...
Contribution of circulating AC133+ stem cells to the replenishment of the satellite cell pool in dystrophic muscles. (A–C) After injection into dystrophic muscle, a few human nuclear lamin A/C–positive cells were distributed near the capillary network (arrows) and regenerating myofibers, identified by a centrally located nucleus (blue after DAPI staining). Double-staining with antibodies against human nuclear lamin A/C (A) and M-cadherin (B) shows that some donor cells express markers typical of satellite cells both outside and underneath (arrowheads) the basal lamina (identified by laminin staining in green). These cells appear pink in the merged image (C) of A and B. (D) Note the presence of several donor lamin A/C (red) cells and M-cadherin (green) double-positive cells (arrowheads) with nuclei localized at the periphery of the fibers under the sarcolemma. (E) We injected a PKH26-labeled AC133 population intramuscularly and sorted PKH26 cells from muscle-derived cells of three scid/mdx mice injected 21 days before. The gated area shown in the top left screen of E corresponds to the sorted population of PKH26-labeled injected cells (inset) that had been stained with anti–M-cadherin (5% of the total PKH26-sorted cells) and resulted in mostly CD34– cells. Few of these cells expressed bright fluorescence such as that of nondividing cells (arrows in inset of E). (F) Expression of endothelial and myogenic markers within three injected TA muscles (M1, M2, and M3) 45 days after injection of AC133+ cells isolated from the blood was also demonstrated by RT-PCR. +, positive control; –, negative control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts